Achillion Financial Statements
Achillion Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Achillion Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 4.0 | 3.3 | 8.5 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (30.6) | (24.3) | (12.7) |
| Total Net Income ($ mil.) | (28.1) | (24.1) | (13.6) |
| Diluted EPS (Net Income) | (1.80) | (9.35) | (4.12) |
Achillion Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 9.89 | 3.81 | 1.53 |
| Price/Earnings Ratio | -- | 16.07 | 15.12 |
| Price/Book Ratio | 1.89 | 2.80 | 1.46 |
| Price/Cash Flow Ratio | -- | 11.72 | 9.52 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Achillion Financial Ratios
Achillion Competitive Intelligence
| GlaxoSmithKline | Johnson & Johnson | Roche | |
|---|---|---|---|
| Annual Sales ($ mil.) | 45,816.1 | 61,095.0 | 34,465.2 |
| Employees | -- | -- | 74,372 |
| Market Cap ($ mil.) | -- | 190,679.1 | -- |
Competitive Landscape
